Developer docs
API playgroundTry for free, no card

Search company profiles

SaltMED

Full company profile

uuid000otdr

Namestring
SaltMED
Legal namestring
Med-Aesthetics Solutions, Inc.
Websiteurl
saltmed.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

SaltMED (legal entity Med-Aesthetics Solutions, Inc., incorporated 2005, rebranded SaltMED in March 2021) designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical aesthetic device that combines three modalities on a single platform: positive-pressure sea salt resurfacing, cavitation aesthetic ultrasound, and medical-grade LED phototherapy (blue, red, near-infrared). The device is sold B2B to dermatologists, plastic surgeons, cosmetic surgeons, med spas, and physician assistants primarily in the United States, with a stated worldwide reach. SaltMED monetizes through one-time device sales, recurring consumable purchases (Salt Kit, Gliding Gel), and practitioner training services. Go-to-market combines enterprise field sales, inside sales via online specialty-specific intake forms, and event-driven demand generation including webinars and industry exhibitions. A provider locator on the company's website drives patient referrals to certified practitioners.

The company's product is differentiated by a patented sea salt delivery handpiece and clinical evidence published in the Journal of Clinical and Cosmetic Dermatology, including outcomes such as a 72.5% reduction in acne-induced inflammation versus 36.8% with antibiotics alone and 5.6-day faster post-surgical recovery. Named customers are board-certified practitioners operating individual practices, with reported utilization as high as 8 hours per day, 6 days per week, and rebooking rates near 70%. Distribution includes a core channel partnership with Merz Aesthetics.

In December 2025, SaltMED was acquired by Micro Imaging Technology, Inc. (MIT/MMTC), a California-based public company, which subsequently announced the acquisition of Cellmyx in June 2026 to create a combined aesthetics and regenerative medicine manufacturing and distribution platform with stated national and worldwide ambitions. SaltMED operates from its headquarters and manufacturing facility, both in Irvine, California.

Short descriptiontext

SaltMED designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical device combining sea salt resurfacing, ultrasound, and LED phototherapy, sold B2B to dermatologists, plastic surgeons, and med spas in the US with worldwide reach.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCardiff By The Sea, United States
HQ citystring
Cardiff By The Sea
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetic equipment, skin renewal therapy, medical facial device, LED phototherapy device, aesthetic ultrasound system
Industry1 code
1Salt Therapy (Halotherapy)
CodeHSADAKAJPrimaryYes
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetic Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of The SaltFacial multi-modality platform device to physicians, healthcare providers, med spas, dermatologists, and plastic surgeons. The device is a Class 2 medical device available for purchase and use in medically supervised facilities.

saltmed.com
2Consumable Products
TypeSubscription Recurring
Description

Recurring sales of consumable supplies including Salt Kit and Gliding Gel required for The SaltFacial treatments. Healthcare providers order supplies through the website order form.

saltmed.com
3Professional Services and Training
TypeProfessional Services
Description

Training and support services for practitioners. A dedicated Training & Support Resources Center provides ongoing education for certified SaltFacial providers.

saltmed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1The SaltFacial Device - Quote-based pricing for medical equipment
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Direct purchase available for physicians and healthcare providers. Quote-based pricing requiring consultation with SaltMED sales team.

saltmed.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1The SaltFacial
Description

A Class II medical facial device that combines three technologies: sea salt resurfacing, aesthetic ultrasound, and LED phototherapy for skin renewal therapy.

saltmed.com
Core offering1 text field

SaltMED manufactures and sells The SaltFacial, an FDA-cleared Class II medical device that combines three modalities—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—into one platform for non-invasive skin renewal therapy. The company sells the device directly to physicians, dermatologists, plastic surgeons, and medical spas, and generates recurring revenue through consumable supplies (Salt Kit and Gliding Gel) required to perform treatments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 100% patient satisfaction rate with 80% reporting being extremely satisfied
+4 more records
Product overview1 text field

SaltMED offers The SaltFacial®, a multi-modality platform system combining three distinct technologies: Sea Salt Resurfacing, Aesthetic Ultrasound, and LED Phototherapy. The core product is The SaltFacial Class II medical device that delivers a three-step skin renewal therapy. The system can be used as an integrated 3-step treatment or each modality used independently. Consumable supplies include Salt Kits and Gliding Gel.

Product and service1 record
1The SaltFacial
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthersAnnounced on2025-12-01
Description

MIT acquired SaltMED/SaltFacial in December 2025, making SaltMED part of a larger public company (MMTC) focused on medical imaging and aesthetics. This acquisition complements MIT's broader portfolio including Cellmyx acquisition, strengthening manufacturing and distribution capabilities nationally and worldwide.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Merz Aesthetics partnership validates The SaltFacial as a premium, scientifically-backed technology in the medical aesthetics market. Dr. Werschler specifically cited the Merz partnership as invoking trust from patients and practitioners. The partnership positions SaltMED within Merz's established distribution network for aesthetic devices.

Strategic tierMinorTypeOthers
Description

Jaanuu is listed as a partner on SaltMED's website footer. Jaanuu is a healthcare apparel brand, suggesting a cross-promotional or co-marketing relationship within the healthcare/aesthetics industry.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cynosure produces aesthetic and medical laser/light platforms (Potenza, TempSure, Mona Lisa Touch) targeting dermatology and plastic surgery practices that overlap with SaltMED's customer base.

TypeBroad incumbent
Description

InMode develops minimally invasive and non-invasive aesthetic platforms (Morpheus8, Evoke, EmpowerRF) sold to the same physician and med-spa channel as SaltMED.

TypeBroad incumbent
Description

Lumenis manufactures light-based and energy-based aesthetic and surgical devices (M22, Stellar, SPLENDOR X) sold into the same physician customer accounts as The SaltFacial.

4Edge Systems (HydraFacial)
TypeDirect peer
Description

Edge Systems manufactures the HydraFacial device, the most direct category competitor to The SaltFacial: a multi-step skin treatment platform sold to med-spas, dermatologists, and plastic surgeons with both device and recurring serum/consumable revenue.

TypeBroad incumbent
Description

Cutera manufactures aesthetic laser and light-based devices (e.g., AviClear, excel V, truSculpt) sold to the same physician and med-spa accounts, competing for the device capital budget that SaltMED depends on.

TypeBroad incumbent
Description

Sciton makes multi-modality aesthetic laser and light platforms (BBL, Halo, mJOULE) sold to medical practices and med-spas, directly overlapping SaltMED's pre/post-procedure positioning.

TypeBroad incumbent
Description

BTL makes non-invasive aesthetic devices (EMFACE, Emsculpt, Exilis) for facial and body rejuvenation, often sold to the same dermatology, plastic surgery, and med-spa buyers as SaltMED.

TypeBroad incumbent
Description

Alma Lasers produces a broad portfolio of aesthetic laser, light, RF, and ultrasound platforms (Accent, Harmony XL, Soprano) sold into the same med-spa and physician channel as The SaltFacial.

TypeOthers
Description

Strategic channel partner rather than a direct device competitor; Merz Aesthetics distributes injectables and Ultherapy, and partners with SaltMED to bundle Ultherapy with The SaltFacial, reaching the same aesthetic practices through its sales network.

TypeBroad incumbent
Description

Solta (Thermage, Fraxel, Clear+Brilliant) is a broader aesthetic device incumbent that sells energy-based skin rejuvenation platforms into the same dermatologist and plastic surgeon channels SaltMED targets, with multi-modality positioning similar to The SaltFacial.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SaltMED

Medical Aesthetic Equipmentsaltmed.com

SaltMED designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical device combining sea salt resurfacing, ultrasound, and LED phototherapy, sold B2B to dermatologists, plastic surgeons, and med spas in the US with worldwide reach.

What SaltMED does

SaltMED (legal entity Med-Aesthetics Solutions, Inc., incorporated 2005, rebranded SaltMED in March 2021) designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical aesthetic device that combines three modalities on a single platform: positive-pressure sea salt resurfacing, cavitation aesthetic ultrasound, and medical-grade LED phototherapy (blue, red, near-infrared). The device is sold B2B to dermatologists, plastic surgeons, cosmetic surgeons, med spas, and physician assistants primarily in the United States, with a stated worldwide reach. SaltMED monetizes through one-time device sales, recurring consumable purchases (Salt Kit, Gliding Gel), and practitioner training services. Go-to-market combines enterprise field sales, inside sales via online specialty-specific intake forms, and event-driven demand generation including webinars and industry exhibitions. A provider locator on the company's website drives patient referrals to certified practitioners.

The company's product is differentiated by a patented sea salt delivery handpiece and clinical evidence published in the Journal of Clinical and Cosmetic Dermatology, including outcomes such as a 72.5% reduction in acne-induced inflammation versus 36.8% with antibiotics alone and 5.6-day faster post-surgical recovery. Named customers are board-certified practitioners operating individual practices, with reported utilization as high as 8 hours per day, 6 days per week, and rebooking rates near 70%. Distribution includes a core channel partnership with Merz Aesthetics.

In December 2025, SaltMED was acquired by Micro Imaging Technology, Inc. (MIT/MMTC), a California-based public company, which subsequently announced the acquisition of Cellmyx in June 2026 to create a combined aesthetics and regenerative medicine manufacturing and distribution platform with stated national and worldwide ambitions. SaltMED operates from its headquarters and manufacturing facility, both in Irvine, California.

SaltMED firmographics

Firmographics
Name
SaltMED
Legal name
Med-Aesthetics Solutions, Inc.
Website
https://saltmed.com
Company type
Private
Founded year
2005
Operating status
Acquired
Headcount range
11–50 employees
Short description
SaltMED designs, manufactures, and sells The SaltFacial, a Class II FDA-cleared medical device combining sea salt resurfacing, ultrasound, and LED phototherapy, sold B2B to dermatologists, plastic surgeons, and med spas in the US with worldwide reach.
Ownership category
akta.pro rank

SaltMED industry classification

Industry
Product category
Medical Aesthetic Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Salt Therapy (Halotherapy) (HSADAKAJ)

Keywords

  • Medical aesthetic equipment
  • Skin renewal therapy
  • Medical facial device
  • LED phototherapy device
  • Aesthetic ultrasound system

Where SaltMED is headquartered

Location

Headquarters

HQ city
Cardiff By The Sea
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SaltMED business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Device Sales: Sale of The SaltFacial multi-modality platform device to physicians, healthcare providers, med spas, dermatologists, and plastic surgeons. The device is a Class 2 medical device available for purchase and use in medically supervised facilities.
  2. Consumable Products: Recurring sales of consumable supplies including Salt Kit and Gliding Gel required for The SaltFacial treatments. Healthcare providers order supplies through the website order form.
  3. Professional Services and Training: Training and support services for practitioners. A dedicated Training & Support Resources Center provides ongoing education for certified SaltFacial providers.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractThe SaltFacial Device - Quote-based pricing for medical equipment

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

SaltMED product offering

Product offering

Core offering

SaltMED manufactures and sells The SaltFacial, an FDA-cleared Class II medical device that combines three modalities—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—into one platform for non-invasive skin renewal therapy. The company sells the device directly to physicians, dermatologists, plastic surgeons, and medical spas, and generates recurring revenue through consumable supplies (Salt Kit and Gliding Gel) required to perform treatments.

Product overview

SaltMED offers The SaltFacial®, a multi-modality platform system combining three distinct technologies: Sea Salt Resurfacing, Aesthetic Ultrasound, and LED Phototherapy. The core product is The SaltFacial Class II medical device that delivers a three-step skin renewal therapy. The system can be used as an integrated 3-step treatment or each modality used independently. Consumable supplies include Salt Kits and Gliding Gel.

Differentiator

Problem solved

Functional benefit

Brands

  • The SaltFacial: A Class II medical facial device that combines three technologies: sea salt resurfacing, aesthetic ultrasound, and LED phototherapy for skin renewal therapy.

Products and services

  • The SaltFacial

Quantifiable outcome

  • 100% patient satisfaction rate with 80% reporting being extremely satisfied
  • +4 more outcomes

Companies that use SaltMED

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles1 record

SaltMED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SaltMED partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Micro Imaging Technology (MIT)coreOthers · 1 December 2025MIT acquired SaltMED/SaltFacial in December 2025, making SaltMED part of a larger public company (MMTC) focused on medical imaging and aesthetics. This acquisition complements MIT's broader portfolio including Cellmyx acquisition, strengthening manufacturing and distribution capabilities nationally and worldwide.
  • Merz AestheticscoreChannel Partner/ Reseller/ DistributorMerz Aesthetics partnership validates The SaltFacial as a premium, scientifically-backed technology in the medical aesthetics market. Dr. Werschler specifically cited the Merz partnership as invoking trust from patients and practitioners. The partnership positions SaltMED within Merz's established distribution network for aesthetic devices.
  • JaanuuminorOthersJaanuu is listed as a partner on SaltMED's website footer. Jaanuu is a healthcare apparel brand, suggesting a cross-promotional or co-marketing relationship within the healthcare/aesthetics industry.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

SaltMED competitors and assessment

Company assessment

Broad incumbents

  • Cynosure: Cynosure produces aesthetic and medical laser/light platforms (Potenza, TempSure, Mona Lisa Touch) targeting dermatology and plastic surgery practices that overlap with SaltMED's customer base.
  • InMode: InMode develops minimally invasive and non-invasive aesthetic platforms (Morpheus8, Evoke, EmpowerRF) sold to the same physician and med-spa channel as SaltMED.
  • Lumenis: Lumenis manufactures light-based and energy-based aesthetic and surgical devices (M22, Stellar, SPLENDOR X) sold into the same physician customer accounts as The SaltFacial.
  • Cutera: Cutera manufactures aesthetic laser and light-based devices (e.g., AviClear, excel V, truSculpt) sold to the same physician and med-spa accounts, competing for the device capital budget that SaltMED depends on.
  • Sciton: Sciton makes multi-modality aesthetic laser and light platforms (BBL, Halo, mJOULE) sold to medical practices and med-spas, directly overlapping SaltMED's pre/post-procedure positioning.
  • BTL Industries: BTL makes non-invasive aesthetic devices (EMFACE, Emsculpt, Exilis) for facial and body rejuvenation, often sold to the same dermatology, plastic surgery, and med-spa buyers as SaltMED.
  • Alma Lasers: Alma Lasers produces a broad portfolio of aesthetic laser, light, RF, and ultrasound platforms (Accent, Harmony XL, Soprano) sold into the same med-spa and physician channel as The SaltFacial.
  • Solta Medical: Solta (Thermage, Fraxel, Clear+Brilliant) is a broader aesthetic device incumbent that sells energy-based skin rejuvenation platforms into the same dermatologist and plastic surgeon channels SaltMED targets, with multi-modality positioning similar to The SaltFacial.

Direct peers

  • Edge Systems (HydraFacial): Edge Systems manufactures the HydraFacial device, the most direct category competitor to The SaltFacial: a multi-step skin treatment platform sold to med-spas, dermatologists, and plastic surgeons with both device and recurring serum/consumable revenue.

Others

  • Merz Aesthetics: Strategic channel partner rather than a direct device competitor; Merz Aesthetics distributes injectables and Ultherapy, and partners with SaltMED to bundle Ultherapy with The SaltFacial, reaching the same aesthetic practices through its sales network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

SaltMED social profiles

Digital presence

SaltMED compliance and trust

Trust signal

Compliance1 record

SaltMED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SaltMED leadership team

Management profile

Number of profiles

SaltMED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SaltMED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SaltMED

What does SaltMED do?

SaltMED manufactures and sells The SaltFacial, an FDA-cleared Class II medical device that combines three modalities—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—into one platform for non-invasive skin renewal therapy. The company sells the device directly to physicians, dermatologists, plastic surgeons, and medical spas, and generates recurring revenue through consumable supplies (Salt Kit and Gliding Gel) required to perform treatments.

Is SaltMED a public or private company?

SaltMED is a private company. It is classified as corporate owned and is currently acquired.

When was SaltMED founded?

SaltMED was founded in 2005. It employs 11 to 50 people.

Where is SaltMED based?

SaltMED is headquartered in Cardiff By The Sea, United States, in the North America region.

How does SaltMED make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are consumable Products and professional Services and Training.

Who are SaltMED's main competitors?

Broad incumbents on record are Cynosure, InMode, Lumenis, Cutera, Sciton, BTL Industries, Alma Lasers and Solta Medical. Edge Systems (HydraFacial) is listed as a direct peer. Merz Aesthetics is listed as an others.

Does SaltMED have an API?

No public API is recorded for SaltMED.

What industry is SaltMED in?

SaltMED's product category is Medical Aesthetic Equipment. Its primary akta.pro industry code is HSADAKAJ, Salt Therapy (Halotherapy). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Globe and MailMicro Imaging Technology Details SaltMED Asset Acquisition StrategyMicro Imaging Technology completed a purchase of SaltMED assets from a trustee's sale on December 24, 2025, after negotiating from September through December 2025. The acquisition, disclosed in a March 18, 2026 report signed by CEO Jeffrey Nunez, aims to broaden its asset base and strengthen operational control in its markets.PR NewswireNew Study Demonstrates The SaltFacial's Non-Invasive Method for Enhancing Efficacy of Exosomes and Improving Skin QualityA new study published in the Journal of Cosmetic Dermatology has demonstrated that The SaltFacial, a non-invasive three-step skin rejuvenation treatment, can significantly enhance the efficacy of exosomes and improve skin quality without breaking the skin. The research showed that combining The SaltFacial's sea salt exfoliation, ultrasound, and LED light therapy technologies enables more effective delivery of exosomes to deeper skin layers, resulting in improved skin texture, firmness, and elasticity. SaltMED, the company behind the treatment, released these findings as the first publication to validate this combination approach for non-invasive skin rejuvenation.PR NewswireSaltFacial: A Novel Combination Therapy in Aesthetic Medicine and Reconstructive Surgery: Outperforms Old Standards for Aging Skin, Acne, Infection, & Wound HealingA research study authored by Dr. Gregory Chernoff at Chernoff Plastic Surgery, published in the Journal of Clinical and Cosmetic Dermatology, found that The SaltFacial — a three-technology platform manufactured by SaltMED — outperformed traditional treatments for aging skin, acne, and post-surgical wound healing. In clinical trials involving 92 patients, The SaltFacial achieved 80% patient satisfaction for anti-aging results, reduced acne-induced inflammation by 72.5% compared to 36.8% with antibiotics alone, and shortened post-surgical infection recovery by 5.6 days. SaltMED, incorporated in 2005, is positioning the device as an effective single-session treatment across aesthetic, dermatologic, and surgical applications.PR NewswireMed-Aesthetic Solutions, Inc Rebrands as SaltMed™ and Showcases 'The SaltFacial's®' New Brand Identity as The World's First Class 2 Medical-Facial DeviceMedical Aesthetic Solutions, Inc. has rebranded as SaltMed™ and introduced a new corporate identity for its signature product, The SaltFacial®, positioning it as the world's first Class-2 medical-facial device for non-thermal skin resurfacing and rejuvenation. The device combines three technologies—sea salt resurfacing, aesthetic ultrasound, and LED phototherapy—and is used by dermatologists, plastic surgeons, and medical spas globally. The rebranding follows the company's efforts to establish The SaltFacial as the emerging gold standard in the skin rejuvenation category.